1 – 5 of 13
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Ågerstam, Helena LU ; Hansen, Nils LU ; von Palffy, Sofia LU ; Sandén, Carl LU ; Reckzeh, Kristian LU ; Karlsson, Christine LU ; Lilljebjörn, Henrik LU
;
Landberg, Niklas
LU
;
Askmyr, Maria
LU
and
Högberg, Carl
LU
, et al.
(2016)
In Blood
128(23).
p.2683-2693
Mark
- Leukemic stem cell quantification in newly diagnosed chronic myeloid leukemia patients predicts response to nilotinib therapy
- Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
- 2015
- Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
- 2012
- Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia